Top Markets
#1 MowCat MowCat +369.51%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.53%
#3 SODAX SODAX +49.56%
#4 Cortex Cortex +33.79%
#5 OpenEden OpenEden +23.46%
#6 DexNet DexNet +23.19%
#7 BNB Attestation Service BNB Attestation Service +17.83%
#8 Magma Finance Magma Finance +17.79%
#9 Akedo Akedo +16.46%
#10 wojak wojak +16.43%
Coin of the day
MowCat MowCat
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
China National Accord Medicines Corporation Ltd. China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd.

000028
Classificação em ações #7536
China National Accord Medicines Corporation Ltd. primarily focuses on the... China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.
Preço da ação
$2.90
Valor de mercado
$1.55B
Variação (1 dia)
0.15%
Variação (1 ano)
-11.06%
País
CN
Negociar China National Accord Medicines Corporation Ltd. (000028)

Categoria

Healthcare
Rácio P/E de China National Accord Medicines Corporation Ltd. (000028)
Rácio P/E em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da China National Accord Medicines Corporation Ltd., o rácio P/E atual (TTM) é 0. No final de 2026, a empresa tinha um P/E de 0.
Histórico do rácio P/E da China National Accord Medicines Corporation Ltd. de 2026 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 23.15 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 32.35 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 -338.64 -
AU
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.